Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Control of HIV-1 Infection By Ferroportin Q248H Mutation

Namita Kumari, PhD, Seyed Mehdi Nouraie, PhD MD, Hatajai Lassiter, MS, BS, Asrar Ahmad, PhD, Kathryn Anastos, Jason Lazar, Seble Kassaye, Bradley Aouizerat, Audrey French, Stephen Gange, Adaora Adimora, Neale Weitzmann, Margaret Fischl, Mirjam-Colette Kempf, Sergei Nekhai, PhD

Blood (2019) 134 (Supplement_1): 953.

https://doi.org/10.1182/blood-2019-128685

Published: 2019

Journal Articles

Interrogation of Individual CLL Loss-of-Function Lesions By CRISPR In Vivo Editing Reveals Common and Unique Pathway Alterations

Blood (2019) 134 (Supplement_1): 684.

https://doi.org/10.1182/blood-2019-127673

Published: 2019

Journal Articles

Australian Familial Haematological Cancer Study - Findings from 15 Years of Aggregated Clinical, Genomic and Transcriptomic Data

Christopher N Hahn, PhD, Milena Babic, BMPharBio (Hons), Peter J Brautigan, BSc (Hons), Parvathy Venugopal, PhD MSc, BSc, Kerry Phillips, Julia Dobbins, BSc (Hons), Peer Arts, PhD, Amilia Wee, BSc (Hons), Deepak Singhal, MBBS,MDFRACP,FRCPA, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Jinghua Feng, PhD, Andreas W Schreiber, PhD, Richard J D'Andrea, PhD, Nicola Poplawski, MD, Anna L Brown, PhD, Hamish S Scott, PhD FFSc (RCPA)

Blood (2019) 134 (Supplement_1): 1439.

https://doi.org/10.1182/blood-2019-131686

Published: 2019

Journal Articles

Synergistic Pre-Clinical Activity of Targeted Inhibition of KDM1A and BET Proteins Against Human AML Blast Progenitor Cells

Warren Fiskus, BSc, PhD, Christopher Peter Mill, PhD BA, Raffaella Soldi, Roulan Han, Dyana T. Saenz, PhD, Agnieszka J Nowak, Baohua Sun, MD PhD, David N Saenz, Courtney D. DiNardo, MD MSc, Gautam Borthakur, MD, Tapan M. Kadia, MD, Wendy Jin, Thurika Ganesh, Vaishnavi Rao, Joseph David Khoury, MD, Sunil Sharma, MD, Kapil N. Bhalla, MD

Blood (2018) 132 (Supplement 1): 3930.

https://doi.org/10.1182/blood-2018-99-114198

Published: 2018

Journal Articles

The Novel Tumor Suppressor SAMHD1 Is Differentially Expressed and Partly Regulated By MYC in Peripheral T-Cell Lymphomas (PTCL)

Pedro Farrajota Neves Da Silva, MD, Nikolaos Tsesmetzis, Ioanna Xagoraris, MD, Agata Magdalena Wasik, PhD MSc, Georgia Kokaraki, PhD, Evangelos Tzoras, Anders Österborg, MD PhD Prof., Birgitta Sander, MD PhD, Nikolas Herold, MD PhD, George Rassidakis, MD PhD

Blood (2018) 132 (Supplement 1): 4130.

https://doi.org/10.1182/blood-2018-99-119229

Published: 2018

Journal Articles

Restriction of HIV-1 Infection in Sickle Cell Disease and Trait

Namita Kumari, PhD, Miguel de Mulder, PhD, Javed Khan, PhD, Asrar Ahmad, PhD, Songping Wang, Hatajai Lassiter, Nathan Smith, Nowah Kokou Apeadoufia Afangbedji, Andrey Ivanov, PhD, Mitsu Shah, Sharmin Diaz, Sohail Rana, MD, Douglas Nixon, PhD, Sergei Nekhai, PhD

Blood (2018) 132 (Supplement 1): 2337.

https://doi.org/10.1182/blood-2018-99-117029

Published: 2018

Journal Articles

SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival

Agata Magdalena Wasik, PhD MSc, Elin Marin, MD, Magali Merrien, MSc, Joana de Matos Rodrigues, PhDstudent, Martin Lord, PhD, Ioanna Xagoraris, MD, Birger Christensson, MD PhD, George Rassidakis, MD PhD, Mats Jerkeman, Sara Ek, PhD, Birgitta Sander, MD PhD

Blood (2018) 132 (Supplement 1): 4136.

https://doi.org/10.1182/blood-2018-99-118087

Published: 2018

Journal Articles

Hemin and Iron Modulated Intrinsic Cellular Factors Regulate HIV-1 Replication in Sickle Cell Disease

Namita Kumari, PhD, Miguel de Mulder, Nowah Kokou Apeadoufia Afangbedji, Songping Wang, Sharmin Diaz, NP, Douglas Nixon, Sergei Nekhai, PhD

Blood (2017) 130 (Supplement 1): 3492.

https://doi.org/10.1182/blood.V130.Suppl_1.3492.3492

Published: 2017

Journal Articles

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

Blood (2017) 130 (Supplement 1): 259.

https://doi.org/10.1182/blood.V130.Suppl_1.259.259

Published: 2017

Journal Articles

BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia

Blood (2017) 130 (Supplement 1): 260.

https://doi.org/10.1182/blood.V130.Suppl_1.260.260

Published: 2017

Journal Articles

Downregulation of the Tumor Suppressor SAMHD1 in Classical Hodgkin Lymphoma

Ioanna Xagoraris, MD, Theodoros Vassilakopoulos, MDPhD, Nikolas Herold, MDPhD, Nikolaos Tsesmetzis, MSc., Elias Drakos, MD PhD, Joseph David Khoury, MD, George Rassidakis, MD PhD

Blood (2017) 130 (Supplement 1): 1480.

https://doi.org/10.1182/blood.V130.Suppl_1.1480.1480

Published: 2017

Journal Articles

Restriction of HIV-1 Infection in Sickle Cell Disease Trait

Namita Kumari, PhD, Javed Khan, Tatiana Ammosova, PhD, Asrar Ahmad, Sharmin Diaz, NP, Sohail Rana, MD, Sergei Nekhai, PhD

Blood (2017) 130 (Supplement 1): 940.

https://doi.org/10.1182/blood.V130.Suppl_1.940.940

Published: 2017

Journal Articles

Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens

George Rassidakis, MD PhD, Herold Nikolas, MD PhD, Ida Hed Hed Myrberg, PhD, Nikolaos Tsesmetzis, MSc., Dan Grander, MD PhD, Hagop M. Kantarjian, MD, L. Jeffrey Medeiros, MD, Ioanna Xagoraris, MD, Joseph David Khoury, MD

Blood (2017) 130 (Supplement 1): 3928.

https://doi.org/10.1182/blood.V130.Suppl_1.3928.3928

Published: 2017

Journal Articles

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker

Anna Stengel, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 4001.

https://doi.org/10.1182/blood.V130.Suppl_1.4001.4001

Published: 2017

Journal Articles

Impact of Infrequently Mutated Genes on Prognosis in 531 Untreated CLL Patients

Sabine Jeromin, PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Wolfgang Kern, MD

Blood (2017) 130 (Supplement 1): 3005.

https://doi.org/10.1182/blood.V130.Suppl_1.3005.3005

Published: 2017

Journal Articles

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Donát Alpár, PhD, Dóra Marosvári, MD, Richárd Kiss, Viktória Fésüs, Ambrus Gángó, MD, Noémi Nagy, Péter Farkas, MD, Szabolcs Tasnády, PhD, Marienn Réty, MD, Andras Matolcsy, MD PhD, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD

Blood (2017) 130 (Supplement 1): 1457.

https://doi.org/10.1182/blood.V130.Suppl_1.1457.1457

Published: 2017

Journal Articles

Clonal Evolution of Molecular and Cytogenetic Aberrations in 80 CLL Patients

Sabine Jeromin, PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Wolfgang Kern, MD

Blood (2017) 130 (Supplement 1): 1720.

https://doi.org/10.1182/blood.V130.Suppl_1.1720.1720

Published: 2017

Journal Articles

Increased Iron Export By Ferroportin Induces Restriction of HIV-1 Infection in Sickle Cell Disease By SAMHD1

Namita Kumari, PhD, Tatiana Ammosova, Sharmeen Diaz, Xionghao Lin, PhD, Xiaomei Niu, Andrey Ivanov, Subhash Dhawan, Patricia A. Oneal, MD, Sergei Nekhai, PhD

Blood (2016) 128 (22): 201.

https://doi.org/10.1182/blood.V128.22.201.201

Published: 2016

Journal Articles

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Blood (2016) 128 (22): 194.

https://doi.org/10.1182/blood.V128.22.194.194

Published: 2016

Journal Articles

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Pauline Robbe, Kate Ridout, Jennifer Becq, Miao He, Ruth Clifford, MD, Reem Alsolami, Adam Burns, Samantha JL Knight, Melanie Oates, Dena Howard, Andrew R. Pettitt, Augusto Rendon, Niko Popitsch, Peter Hillmen, Jenny C Taylor, Mark Caulfield, David Bentley, Clare Turnbull, Anna Schuh, MD PhD

Blood (2016) 128 (22): 2022.

https://doi.org/10.1182/blood.V128.22.2022.2022

Published: 2016

NARROW

Control of HIV-1 Infection By Ferroportin Q248H Mutation

Interrogation of Individual CLL Loss-of-Function Lesions By CRISPR In Vivo Editing Reveals Common and Unique Pathway Alterations

Australian Familial Haematological Cancer Study - Findings from 15 Years of Aggregated Clinical, Genomic and Transcriptomic Data

Synergistic Pre-Clinical Activity of Targeted Inhibition of KDM1A and BET Proteins Against Human AML Blast Progenitor Cells

The Novel Tumor Suppressor SAMHD1 Is Differentially Expressed and Partly Regulated By MYC in Peripheral T-Cell Lymphomas (PTCL)

Restriction of HIV-1 Infection in Sickle Cell Disease and Trait

SAMHD1 Is Variably Expressed in Mantle Cell Lymphoma and Correlated to SOX11 but Not to Survival

Hemin and Iron Modulated Intrinsic Cellular Factors Regulate HIV-1 Replication in Sickle Cell Disease

The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial

BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia

Downregulation of the Tumor Suppressor SAMHD1 in Classical Hodgkin Lymphoma

Restriction of HIV-1 Infection in Sickle Cell Disease Trait

Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker

Impact of Infrequently Mutated Genes on Prognosis in 531 Untreated CLL Patients

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Clonal Evolution of Molecular and Cytogenetic Aberrations in 80 CLL Patients

Increased Iron Export By Ferroportin Induces Restriction of HIV-1 Infection in Sickle Cell Disease By SAMHD1

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only